(Q34585047)
Statements
1 reference
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group (English)
1 reference
Terzah M Horton
1 reference
John P Perentesis
1 reference
Alan S Gamis
1 reference
Todd A Alonzo
1 reference
Robert B Gerbing
1 reference
Jennifer Ballard
1 reference
Kathleen Adlard
1 reference
Dianna S Howard
1 reference
Franklin O Smith
1 reference
Gaye Jenkins
1 reference
Angelé Kelder
1 reference
Gerrit J Schuurhuis
1 reference
Jeffrey A Moscow
1 reference
29 June 2014
1 reference
1 reference
61
1 reference
10
1 reference
1754-1760
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference